This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MedTech Summit

HURRY! £300 SAVINGS EXPIRE IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
10 - 14 June 2024
DoubleTree by Hilton Brussels CityBrussels, Belgium (Hybrid Event)
10 - 14 June 2024
DoubleTree by Hilton Brussels City,
Brussels, Belgium (Hybrid Event)

10 - 11 June 2024

Don't Fall Behind: Streamline Your Approach for EU MDR Compliance and Secure Regulatory Success

Prepare for the 2027/ 2028 Transition Deadline with Key Learnings from Notified Bodies, Trade Associations, and Medical Device Manufacturers on the EU MDR, UKCA, and MEDDO

Quickly Navigate the Changes Around Orphan Devices, Industry Innovation, Legacy Devices, EUDAMED, Labelling & UDI, and Much More...

Quickly Overcome The Hurdles of European Medical Device Submission

Explore Wider Regulatory Topics and Enhance Overall Compliance Capabilities

  • Shifting from siloed to holistic perspectives: gain insight into the latest harmonisation efforts alongside Intersurgical  
  • Help to boost innovation in industry through our multi-stakeholder panel from TÜV SÜD, AKRA Team GmBH and Abbott  
  • Evaluate MDR’s effect on workloads and gain best practices to enhance employee happiness

Apply Multi-Stakeholder Experience to Navigate Device Submissions Under EU MDR

  • Ensure successful MDR transition by understanding current timelines and deadlines 
  • Learn best practices for maintaining legacy devices with help from Axon Lawyers
  • Apply Medical Device Project B.V’s learnings for regulating orphan devices 

Get the Latest Regulatory Updates Across all European Markets

  • Utilise cross-industry experience with EU MDR to refine current working practices and accelerate device certification 
  • UKCA: What do we know about the proposed regulations and how aligned are they with MDR? 
  • Accessing Switzerland: How will the Mutual Recognition Agreement help to streamline documentation across markets?